Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Poland-based independent integrated drug discovery provider Selvita has agreed to offer computational chemistry services to the Institutes for Pharmaceutical Discovery (IPD), the parent company of the Institute for Drug Discovery (IDD) and The Institute for Bioanalytics.
Subscribe to our email newsletter
The tie up aims to identify new chemical compounds that slow down the activity of novel protein target, proposed by IPD.
The results of the computational analysis will be experimentally tested in drug discovery research conducted by IPD.
IPD Synthetic Medicinal Chemistry senior director Paul Beckett said they expect to identify a set of chemical structures possessing the desired characteristics of specific functional inhibitors, with potential therapeutic activity.